CARDOZA GEORGE 4

What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 774 shares on June 22, 2026, for total proceeds of approximately $4,164. The reported weighted-average sale price was $5.38 per share (individual trades ranged $5.33–$5.46). This was a sale to satisfy tax withholding tied to restricted stock units that vested on June 18, 2026, and is generally considered a routine, non-discretionary transaction.

Key Details

• Transaction date: 2026-06-22 (reported on Form 4 filed 2026-06-23). Filing appears timely.
• Amount sold: 774 shares; weighted-average price: $5.38; total proceeds ≈ $4,164.
• Price range: $5.33 to $5.46 across multiple trades (report lists weighted average; reporting person will provide breakdown on request).
• Purpose/footnote: Sale effected pursuant to a pre-established Rule 10b5-1(c) trading plan to satisfy tax withholding obligations from RSU vesting on 2026-06-18 (not a discretionary sell).
• Shares owned after the transaction: not disclosed in the filing.

Context This was a tax-withholding sale related to RSU vesting and executed under a 10b5-1 plan—common for executives and typically not read as a signal of company outlook. Purchases by insiders tend to carry more weight for bullish signals; routine withholding sales are administrative.